Table 3 Average baseline characteristics in 11 patients with COVID-19

Age (years)*

53.50 ± 10.50

54.20 ± 11.50

53.80 ± 10.40

Sex

 Male

4 (80%)

4 (66.70%)

8 (73%)

 Female

1 (20%)

2 (33.30%)

3 (27%)

Comorbid disease

4

2

6 (54.50%)

Fever (> 37.3 °C)

6 (100%)

4 (80%)

10 (91%)

Cough

5 (83.30%)

5 (100%)

10 (91%)

Dyspnea

5 (83.30%)

5 (100%)

10 (91%)

PaO2/FiO2 ratio (IQR)

87.67 (15.00)

69.40 (47.50)

79.39 (35)

Respiratory rate (> 30)

6 (100%)

5 (100%)

11 (100%)

SOFA (min-max)

3–6

3–7

3–7

WBCs

6668 (1451)

14,957 (6581)

10,352 (6160)

Lymphocytes (%)

21.18 (18.00)

5.56 (5.10)

14.08 (8.70)

Lymphocytes < 1000

5 (83%)

4 (80%)

9 (81.8%)

Platelets

199,600 (58439)

178,500 (58563)

190,223 (55831)

PT

15.64 (4.72)

14.50 (0.55)

15.13 (3.41)

PTT

32.60 (11.59)

38.25 (9.95)

35.11 (10.64)

BUN

22.88 (11.26)

35.95 (23.18)

28.69 (17.67)

Cr

1.04 (0.29)

1.76 (1.17)

1.36 (0.83)

LDH

1237 (209)

1122 (500)

1186.33 (345.64)

Median days from first symptom to admission (IQR)

4.5 (10)

11 (4)

10 (10)

Median days from first symptom to first infusion (IQR)

9 (16)

17 (3)

16 (10)